The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
Abstract
This study tests the hypothesis that nicotinic cholinergic receptors, including those sensitive to the antagonist alpha-bungarotoxin, are decreased in the hippocampus of schizophrenics. The hypothesis is derived from the finding that alpha-bungarotoxin causes a defect in the inhibitory gating of auditory-evoked potentials in laboratory animals that resembles a defect in auditory sensory gating observed in schizophrenics. Nicotine transiently normalizes this psychophysiological deficit in schizophrenic patients. Postmortem brain tissue was obtained from eight schizophrenic and eight age-matched nonschizophrenic subjects. Sections of the hippocampus were labeled with [125I alpha-bungarotoxin and imagined by autoradiography. Binding of the nicotinic agonist [3H]-cytisine was determined in tissue homogenates. alpha-Bungarotoxin labeled a population of putative interneurons in the hippocampus, primarily in the dentate gyrus and the CA3 region of Ammon's horn. This labeling was significantly decreased in the tissue from the schizophrenic patients, with seven or eight patients below the range of the nonschizophrenic subjects. There was also a significant decrease in the binding of cytisine. The results were not related to generalized hippocampal cell loss, drug exposure at time of death, or smoking history. This initial study suggests that schizophrenic patients have fewer nicotinic receptors in the hippocampus, a condition which may lead to failure of cholinergic activation of inhibitory interneurons, manifest clinically as decreased gating of response to sensory stimulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, there is convergence between the genetic findings and the neurobiological model, corroborated by postmortem findings of decreased α7-nicotinic receptors in schizophrenia (31).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [31]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citationBenes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 891
Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Self-citationCigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
GOFF, D. C., Henderson, D. C., & Amico, E. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 576
Research works printed but not linked: 3
- Daviss, 1993, Calbindin- and calretinin-immunoreactive local circuit neurons are increased in density in the prefrontal cortex of schizophrenic subjects, Neurosci Abstracts, 19, 201
- Goff, 1980, Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man, Prog Clin Neurophysiol, 7, 126
- Klein, 1991, On the influence of smoking upon smooth pursuit eye movements of schizophrenics and normal controls, J Psychophysiology, 5, 361
Cited by
Sorted by citations
Items 501–600 of 690
Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia
Joshi, Y. B. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_400 · Cited by 11
Tillman, T. S., Chen, Q., Bondarenko, V., Coleman, J. A., Xu, Y., & Tang, P. S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00610 · Cited by 12
Cheng, Q., Lamb, P. W., Stevanovic, K. D., Bernstein, B. J., Fry, S. A., Cushman, J. D., & Yakel, J. L. (2021) · The Journal of Physiology · doi:10.1113/jp280505 · Cited by 11
Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Inada, T., Ozaki, N., & Iwata, N. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0114-8 · Cited by 11
Cholinergic mechanisms in schizophrenia: Current concepts
Raedler, T. J., & Tandon, R. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629410 · Cited by 11
Opportunities in precision psychiatry using PET neuroimaging in psychosis
Coughlin, J. M., Horti, A. G., & Pomper, M. G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.016 · Cited by 11
Anand, R., Stephanie, A., Ponath, G. D., Jordan, I., Nasir, M. I., & Susan, B. (2011) · InTech eBooks · doi:10.5772/20752 · Cited by 11
Molecular Pathology of the Nicotinic Acetylcholine Receptor
Barrantes, F. J. (1998) · Springer eBooks · doi:10.1007/978-3-662-40279-5_8 · Cited by 11
Leonard, S. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00382-2 · Cited by 11
Self-citationHippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Wong, N. R., Rubin, L. H., Harrington, C. K., Jenkins, K. R., Shinehouse, L. K., Yoon, M., Kilgore, J. J., Soule, A. R., Lesniak, W. G., Rowe, S. P., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.27163 · Cited by 10
Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study
Aidelbaum, R., Labelle, A., Baddeley, A., & Knott, V. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117746903 · Cited by 10
Rosse, R. B., Deutsch, S. I., & Chilton, M. (2005) · PubMed · Cited by 10
Xue, Y., He, X., Yang, T., Wang, Y., Liu, Z., Zhang, G., Wang, Y., Wang, K., Zhang, L., & Zhang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111618 · Cited by 10
The smoking cessation drug varenicline improves deficient P20–N40 inhibition in DBA/2 mice
Wildeboer, K. M., & Stevens, K. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.001 · Cited by 9
Iwuagwu, C. I., King, D., McDonald, I. M., Cook, J., Zusi, F. C., Hill, M. D., Mate, R. A., Fang, H., Knox, R. J., Gallagher, L., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.058 · Cited by 9
DNA methylation regulates CHRNA7 transcription and can be modulated by valproate
Dyrvig, M., Mikkelsen, J. D., & Lichota, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.015 · Cited by 9
Nicotine Dependence in Schizophrenia: Contributions of Nicotinic Acetylcholine Receptors
Cole, R. D., & Parikh, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00017-4 · Cited by 9
Nikiforuk, A., Litwa, E., Krawczyk, M., Popik, P., & Arias, H. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00092-4 · Cited by 9
Sofuoglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00012-5 · Cited by 8
Onde P50 dans la schizophrénie
Houy, E., & Thibaut, F. (2007) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(07)48130-5 · Cited by 9
Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels
Brooks, N. P., Mexal, S., & Stitzel, J. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.026 · Cited by 9
Berg, S. A., Sentir, A. M., Bell, R. L., Engleman, E. A., & Chambers, R. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3800-2 · Cited by 10
Choueiry, J., Blais, C. M., Shah, D. K., Smith, D., Fisher, D. J., Ilivitsky, V., & Knott, V. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05646-1 · Cited by 9
Phillips, J. M., Maxwell, C. R., Ehrlichman, R. S., & Siegel, S. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_17 · Cited by 9
Long-lasting changes in neural networks to compensate for altered nicotinic input
John, D., & Berg, D. K. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.020 · Cited by 9
Preclinical Evaluation of Novel PET Probes for Dementia
Cools, R., Kerkhofs, K., Leitao, R. C. F., & Bormans, G. M. (2023) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2023.03.004 · Cited by 9
Smith, D., Fisher, D. J., Blier, P., Ilivitsky, V., & Knott, V. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.008 · Cited by 8
Luckhaus, C., Henning, U., Ferrea, S., Musso, F., Mobascher, A., & Winterer, G. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0743-1 · Cited by 8
Weeks, J. J., Grace, A. A., & Sved, A. F. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab064 · Cited by 8
The Neurochemistry of Schizophrenia
Moghaddam, B., & Krystal, J. H. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch19 · Cited by 8
Abraham, S. M., Suresh, S., & Komal, P. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01586-6 · Cited by 8
Yu, J. (2010) · The Open Behavioral Science Journal · doi:10.2174/1874230001004010009 · Cited by 6
Vingerhoets, C., Bakker, G., Schrantee, A., van der Pluijm, M., Bloemen, O., Reneman, L., Caan, M. W. A., Booij, J., & van Amelsvoort, T. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.06.005 · Cited by 7
Pinho, S., Rocha, V., & Vieira‐Coelho, M. A. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.03.012 · Cited by 9
Dean, B. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903270431 · Cited by 7
Involvement of Neuronal Nicotinic Receptors in Disease
Clementi, F., COURT, J. A., & Perry, E. A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_25 · Cited by 7
Stratilov, V. A., Vetrovoy, O. V., Potapova, S., & Tyulkova, E. I. (2024) · Neuroendocrinology · doi:10.1159/000536214 · Cited by 6
Kuang, G., Wang, X., Halldin, C., Nordberg, A. K., Långström, B., Ågren, H., & Tu, Y. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp02278b · Cited by 6
Ünal, G., & Arıcıoğlu, F. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1379716 · Cited by 6
Tillman, G. D., Spence, J. S., Briggs, R. W., Haley, R. W., Hart, J., & Kraut, M. A. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.11.006 · Cited by 6
Nicotine effect on mismatch negativity in smoking and nonsmoking patients with schizophrenia
Inami, R., & Kirino, E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.002 · Cited by 6
[Smoking and schizophrenia: where is the biological connection?].
Üneri, Ö. Ş., Tural, Ü., & Memik, N. Ç. (2006) · PubMed · Cited by 6
Involvement of neuronal nicotinic receptor in psychiatric disorders.
Suemaru, K., Araki, H., & Gomita, Y. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.295 · Cited by 6
Psychiatry's Remarkable Journey: The Past 40 Years
Pardes, H. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.6.896 · Cited by 6
Salamone, F. N., & Zhou, M. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v5i2.573 · Cited by 6
History of Antipsychotic Drug Development
Shankar, G. S., & Radhakrishnan, R. (2011) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse465 · Cited by 6
Hunter, S. K., Hoffman, M. C., D’Alessandro, A., & Freedman, R. (2024) · Developmental Psychobiology · doi:10.1002/dev.22453 · Cited by 5
Self-citationNeuregulin1 gene variants as a biomarker for cognitive impairments in patients with schizophrenia
Ananloo, E. S., Yoosefee, S., & Karimipour, M. (2020) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2019.12.004 · Cited by 5
Leonard, S. S., & Benfante, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106783 · Cited by 5
Self-citationSwitching Operation Modes in the Neocortex via Cholinergic Neuromodulation
Puigbò, J.-Y., Arsiwalla, X. D., González‐Ballester, M. Á., & Verschure, P. F. M. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01764-w · Cited by 5
Preclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_18 · Cited by 5
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 5
Hashimoto, K., & Hattori, E. (2007) · Medical psychiatry · doi:10.3109/9781420019544.004 · Cited by 5
Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives
Brust, P., & Deuther‐Conrad, W. (2012) · InTech eBooks · doi:10.5772/23787 · Cited by 4
Unconventional PDZ Recognition Revealed in α7 nAChR-PICK1 Complexes
Bondarenko, V., Chen, Q., Tillman, T. S., Xu, Y., & Tang, P. S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00138 · Cited by 4
López-Valdés, H. E., & García‐Colunga, J. (2003) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 4
Conformational analysis of 2-substituted piperazines
Kallel, E. A., Vangel, C., & Elbaum, D. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.05.022 · Cited by 4
Soares, D. D. S., Carvalho, D. R., Ribeiro, M. D. T., Diniz, E., & Neto, A. F. R. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2020-0151 · Cited by 7
Choueiry, J., Blais, C. M., Shah, D. K., Smith, D., Fisher, D. J., Labelle, A., & Knott, V. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231158903 · Cited by 4
Pradhan, A., Mounford, H., Peixinho, J., Rea, E., Epeslidou, E., Scott, J. S., Cull, J., Maxwell, S., Webster, R. G., Beeson, D., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05149-8 · Cited by 4
Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_17 · Cited by 4
Human Brain Imaging of Acetylcholine Receptors
Toyohara, J., Sakata, M., & Ishiwata, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00006-3 · Cited by 4
Ouach, A., Vercouillie, J., Bertrand, E., Rodrigues, N., Pin, F., Sérrière, S., Boiaryna, L., Chartier, A., Percina, N., Tangpong, P., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.049 · Cited by 4
Yu, J., Nagai, T., Ibi, D., Kitahara, Y., Nabeshima, T., & Yamada, K. (2010) · The Open Behavioral Science Journal · Cited by 4
Smoking and Schizophrenia: Prevalence, Mechanisms and Implications for Treatment
Cather, C., Barr, R. S., & Evins, A. E. (2008) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.2.1.5 · Cited by 4
Racemic synthesis of 2′‐substituted nicotine analogs
Rouchaud, A., & Kem, W. R. (2011) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.841 · Cited by 4
Thaker, G. K. (2002) · PubMed · doi:10.1097/01.nmd.0000027590.27232.ed · Cited by 4
Pamoplantar Pustulosis. Pathogenetic Studies with Special Reference to the Role of Nicotine
Hagforsen, E. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4
Real-time tilting and twisting motions of ligand-bound states of α7 nicotinic acetylcholine receptor
Yue, Y., Arai, T., Sasaki, D., Kuramochi, M., Inagaki, H., Ohashi, S., Sekiguchi, H., Mio, K., Kubo, T., & Sasaki, Y. C. (2024) · European Biophysics Journal · doi:10.1007/s00249-023-01693-6 · Cited by 3
Nicotinic acetylcholine receptors in the brain
Barrantes, F. J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00004-4 · Cited by 3
Wakuda, T., Yokokura, M., Magata, Y., Suzuki, C., Murayama, C., Goto, T., Tamayama, T., Kameno, Y., Iwabuchi, T., Isobe, T., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03162-2 · Cited by 3
Liu, S., Babcock, M. S., Bode, J., Chang, J. S., Fischer, H., Garlick, R. L., Gill, G. S., Lund, E. T., Margolis, B. J., Mathews, W. R., et al. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.05.019 · Cited by 3
Kim, D.-U., Lim, B. S., Seok, J.-E., Kim, G. S., Moon, J. S., Lim, C. H., & Lee, C. S. (2023) · Forests · doi:10.3390/f14081565 · Cited by 3
Schulz, J., Brandl, F., Grothe, M. J., Kirschner, M., Kaiser, S., Schmidt, A., Borgwardt, S., Priller, J., Sorg, C., & Avram, M. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad118 · Cited by 5
Cholinergic denervation attenuates phencyclidine-induced c-fos responses in rat cortical neurons
Savage, S., Mattsson, A., & Olson, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.064 · Cited by 3
Nicotine Dependence and Schizophrenia
Basu, A., & Ray, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00025-0 · Cited by 3
Beach, W., Miller, R., & McCurdy, C. R. (1999) · CRC Press eBooks · doi:10.1201/9781420048650.ch11 · Cited by 3
Nicotine Dependence in Schizophrenia: Prevalence, Mechanisms, and Implications for Treatment
Evins, A. E. (2008) · Cited by 3
Nicotinic Acetylcholine Receptors are Possible Therapeutic Targets for Schizophrenia
Kohnomi, S., Suemaru, K., Kawasaki, H., Choshi, T., Hibino, S., & Araki, H. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.197 · Cited by 3
Beneficial Effect of Galantamine on Sensory Information-processing Deficits
Ago, Y. (2010) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.130.1305 · Cited by 3
The neurobiology of schizophrenia
Konopaske, G. T., & Coyle, J. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00056-3 · Cited by 3
What is the Promise of Nicotinergic Compounds in Schizophrenia Treatment?
Mueller, J. K., Rohleder, C., & Leweke, F. M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0154 · Cited by 3
CURRENT PROGRESS IN SCHIZOPHRENIA RESEARCH
Thaker, G. K. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200208000-00009 · Cited by 3
Mastnak-Sokolov, P., Knez, D., Meden, A., Benedik, N. S., Benetik, S. F., Rambaher, M. H., Zorman, M., Nachon, F., Brazzolotto, X., Jardemark, K. E., et al. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111830 · Cited by 3
Chaperoning a7 neuronal nicotinic acetylcholine receptors
Vallés, A. S., & Barrantes, F. J. (2012) · CONICET Digital (CONICET) · Cited by 2
Nicotinic acetylcholine receptors (nACh) in GtoPdb v.2023.3
Gotti, C., Marks, M. J., Millar, N. S., & Wonnacott, S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f76/2023.3 · Cited by 2
Nicotine: A Possible Neuroprotector in Brain Disorders
Alkadhi, K. A., Salim, S., & Alzoubi, K. H. (2025) · Springer eBooks · doi:10.1007/978-3-642-36202-6_178-1 · Cited by 2
Pharmacological approaches to cognitive enhancement
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.016 · Cited by 2
Methyllycaconitine Fails to Inhibit Electrically Precipitated Tonic Hindlimb Extension in Mice
Deutsch, S. I., Rosse, R. B., Bellack, A. S., Billingslea, E. N., & Mastropaolo, J. P. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200303000-00004 · Cited by 2
Lenzi, A., & Tuscano, D. (2004) · International Journal of Pharmaceutical Medicine · doi:10.1097/00124363-200418030-00002 · Cited by 2
Bridgman, A. C., Mackowick, K. M., Goodman, M. S., Rabin, R. A., Barr, M. S., & George, T. P. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0033-8 · Cited by 2
Effects of Smoking on Hormones, Brain, and Behavior
Sidhartha, T., Poland, R. E., & Rao, U. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00108-x · Cited by 2
Acetylcholine Imaging in Psychosis
Vingerhoets, C., Booij, J., & van Amelsvoort, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_15 · Cited by 2
Genetic Regulation of Nicotine-Related Behaviors and Brain Nicotinic Receptors
Stitzel, J. A., Leonard, S. S., & Collins, A. C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_22 · Cited by 2
Self-citationThe Cholinergic Hypothesis: An Introduction to the Hypothesis and a Short History
Friedman, J. I., Kanellopoulou, I., & Novakovic, V. (2012) · doi:10.1002/9781118309421.ch11 · Cited by 2
Walker, M. (2007) · Cited by 2
Nicotinic Receptors and Mental Illness
Leonard, S. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1167-7_20 · Cited by 1
Self-citationHaraldsson, M. H. (2010) · Cited by 1
Nicotinic Acetylcholine Receptor Modulators
Mazurov, A. A., & Yohannes, D. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_56 · Cited by 1
Bachus, S. E., & Kleinman, J. E. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_11 · Cited by 1
Metadata
- Authors
- Freedman, R., Hall, M., Adler, L. E., & Leonard, S.
- Affiliations
- Denver VA Medical Center (US)
- University of Colorado Denver (US)
- Corresponding author
- Freedman, Robert
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 1995-07
- Volume
- 38
- Issue
- 1
- Pages
- 22-33
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2090019512
- Cited by
- 678
- References
- 55
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 18 · 2019: 17 · 2018: 11 · 2017: 17 · 2016: 18 · 2015: 34 · 2014: 29 · 2013: 27 · 2012: 30
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1k01mh000728-01a1)
- National Institute of Mental Health (MH-44212, MH00728, MH 38321, P50MH044212)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, nicotinic acetylcholine receptors, hippocampus, alpha-bungarotoxin binding, auditory gating, inhibitory interneurons, dentate gyrus, CA3 region, postmortem brain, cholinergic dysfunction
- MeSH terms
- Quinolizidine Alkaloids, Adult, Aged, Alkaloids, Autoradiography, Azocines, Binding Sites, Bungarotoxins, Cell Count, Female, Hippocampus, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Quinolizines, Receptors, Nicotinic, Schizophrenia, Cholinergic Agents, Dentate Gyrus, Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review